. Ca 2ϩ then activates specific protein kinases and phosphatases that are involved in VSM contraction and relaxation. 2, 3, 6 Ca 2ϩ may also function as a second messenger to activate other signaling pathways such as cytosolic phospholipase A2␣, phospholipase C, protein kinase C and phosphodiesterase. 6 -8 An increase in [Ca 2ϩ ] i could also modulate plasma membrane channels and pumps such as Ca 2ϩ -activated K ϩ channels and the plasma membrane CaATPase (PMCA). 9,10 Additionally, Ca 2ϩ may affect sarcoplasmic reticulum channels and pumps such as the inositol 1,4,5-trisphosphate (IP 3 ) receptor, the ryanodine-sensitive receptor and intracellular Ca 2ϩ release channels, and the Ca 2ϩ uptake pump (SERCA 
a 2ϩ is a major determinant of many biochemical processes in various cell types, from the beginning of new life and egg fertilization to the end of life and cell death. 1 In vascular smooth muscle (VSM), physiological resting levels of intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) in the nanomolar range are necessary to maintain basal vascular tone. [2] [3] [4] VSM activation is associated with an increase in [Ca 2ϩ ] i in the micromolar range, [2] [3] [4] and large increases in VSM [Ca 2ϩ ] i have been identified in excessive vasoconstriction disorders such as hypertension and coronary vasospasm. 2, 5 Activation of surface membrane receptors in VSM triggers increases in [Ca 2ϩ ] i attributable to Ca 2ϩ release from the intracellular stores in the sarcoplasmic reticulum and Ca 2ϩ entry from the extracellular space through Ca 2ϩ channels (see Figure) . Ca 2ϩ then activates specific protein kinases and phosphatases that are involved in VSM contraction and relaxation. 2, 3, 6 Ca 2ϩ may also function as a second messenger to activate other signaling pathways such as cytosolic phospholipase A2␣, phospholipase C, protein kinase C and phosphodiesterase. 6 -8 An increase in [Ca 2ϩ ] i could also modulate plasma membrane channels and pumps such as Ca 2ϩ -activated K ϩ channels and the plasma membrane CaATPase (PMCA). 9, 10 Additionally, Ca 2ϩ may affect sarcoplasmic reticulum channels and pumps such as the inositol 1,4,5-trisphosphate (IP 3 ) receptor, the ryanodine-sensitive receptor and intracellular Ca 2ϩ release channels, and the Ca 2ϩ uptake pump (SERCA). 11, 12 Calmodulin, a Ca 2؉ Sensor and Regulatory Protein 
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2؉ /CaM in VSM Cell Cycle and Growth
Vascular tissue injury in response to hypoxia, hyperlipidemia, oxidative stress, and nicotine smoking is associated with increased production of growth factors/promoters such as hypoxia-inducible factor, epidermal growth factor, fibroblast growth factor, platelet derived growth factor, angiotensin II, and endothelin-1. [17] [18] [19] [20] [21] [22] The growth factors stimulate the expression and phosphorylation of ERK1/2 and JNK, and increase the DNA binding activity of activator protein-1 (AP-1) and nuclear factor-B (NF-B). 17, 23 These nuclear events induce the phenotypic transformation of VSM into undifferentiated rapidly growing cells. VSM cell (VSMC) growth contributes to the pathogenesis of vascular hypertrophic disorders such as hypertension, atherosclerosis, and vascular restenosis after angioplasty. 24 -26 Studies have implicated Ca 2ϩ as a regulator of mammalian cell cycle during early G 1 phase and near the G 1 to S phase transition. 27 However, the molecular mechanisms underlying the Ca 2ϩ sensitivity of the G 1 /S phase transition in VSM cell cycle have not been clearly elucidated. Also, while some studies have suggested a role for CaM in cell cycle and have shown that Ca 2ϩ /CaM is required for cell proliferation in both unicellular and multicellular eukaryotes, 27,28 the specific molecular targets of the Ca 2ϩ /CaM-dependent pathways are unclear.
Potential Ca 2ϩ /CaM-dependent targets include the serine/ threonine phosphatase calcineurin and the family of multifunctional Ca 2ϩ /CaM-dependent protein kinases (CaMKs). In mammalian cells, both types of enzymes contribute to the regulation of cell cycle progression. However, the mechanism by which Ca 2ϩ /CaM and its downstream targets, particularly calcineurin and CaMKs, regulate key cell cycle-regulatory proteins, remains enigmatic. By understanding how Ca 2ϩ / CaM regulates cell cycle progression in normal mammalian cells, we would gain insight into how hormones control cell division, and how VSMCs coordinate Ca 2ϩ and its down-
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stream targets during the cell transformation into the rapidly growing proliferative phenotype. 28 
Ca 2؉ /CaM-Cyclin Interaction During VSM Cell Cycle
The passage of a cell through the cell cycle is controlled by proteins in the cytoplasm called cyclins. Recent studies have revealed the important role of cyclins in vascular and cardiac tissue injury, inflammation, and wound repair. 29 Cyclins bind to and activate specific cyclin-dependent kinases (CDKs), which in turn phosphorylate a variety of protein substrates that control the cell cycle. Although the levels of CDKs in the cell remain fairly stable, the levels of certain cyclins rise and fall with the specific stages of the cell cycle. Cyclin D and CDK4 mainly control the G 1 phase, cyclins A and E, and CDK2 control the S-phase, while cyclins A and B and CDK1 control the mitotic phase. Growth factors stimulate the expression and tyrosine phosphorylation of ERK-1, which in turn promote the expression of cyclins and induce VSMC growth. 21 On the other hand, a decrease in tyrosine phosphorylation of ERK1/2 reduces the expression of cyclins D1 and E, resulting in G 1 phase cell cycle arrest and inhibition of VSMC proliferation. 30 Studies have shown that depletion of Ca 2ϩ pools in VSMC using the SERCA inhibitor thapsigargin causes inhibition of translocation of activated ERK1/2 to the nucleus and prevents cyclin D1 expression, thus delaying the progression into the S-phase and the cell cycle. 31 Also, forced gene expression of SERCA2a in a model of balloon injury of the rat carotid artery is associated with decreased cyclin D1 in VSMCs, cell cycle arrest at the G1 phase, and reduced VSMC proliferation and neointima formation. 32 Although these studies suggest possible effects of intracellular Ca 2ϩ on cyclin expression and the CDK activity, the specific molecular interactions and targets involved have not been clarified.
In this issue of Circulation Research, Choi and colleagues describe a possible CaM binding site on cyclin E which could be involved in Ca 2ϩ -sensitive G 1 /S transition in VSMCs. 33 They report that the kinase activity of cyclin E/CDK2 was responsive to physiological changes in Ca 2ϩ concentration. Pharmacological inhibition of CaM using calmidazolium abrogated the Ca 2ϩ -sensitivity of cyclin E/CDK2, retarded VSMC proliferation, and caused cell cycle arrest at G 1 phase. A highly conserved 22-aa N-terminal CaM-binding motif in cyclin E genes was essential in mediating the Ca 2ϩ -sensitive kinase activity of cyclin E/CDK2. Mutant cyclin E protein, lacking this CaM-binding motif, did not respond to alterations in Ca 2ϩ concentration. These data clearly suggest that CaMdependent cyclin E/CDK2 activity could mediate the Ca 2ϩ -sensitivity of the G 1 /S transition in VSM cell cycle. These novel findings not only further elucidate the molecular mechanisms underlying VSMC growth, but may also help in the design of therapies that specifically aim at Ca 2ϩ /CaMdependent cyclin E/CDK2 activity and can be used in the Agonist (A)-receptor (R) interaction increases the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP 2 ) and IP 3 production in VSM. IP 3 and then interact with a second site on the receptor to cause its inhibition. 11 Also, the CaATPase (commonly called the Ca 2ϩ pump) is a fine-tuner of intracellular Ca 2ϩ . The plasma membrane CaATPase (PMCA) plays a role in Ca 2ϩ extrusion. PMCA is a large enzyme, with 10 transmembrane domains and a C-terminal cytosolic tail that contains regulatory sites, including a CaM-binding domain. 10 The sarcoplasmic reticulum CaATPase (SERCA) plays a role in Ca 2ϩ reuptake. Reported posttranslational modifications affecting SERCA pump activity involve N-glycosylation, glutathionylation, and CaMKIIdependent phosphorylation. 12 CaM may also be regulated by phosphorylation. CaM is phosphorylated both in vitro and in vivo by multiple serine/ threonine and tyrosine protein kinases. Casein kinase II and MLC kinase are two serine/threonine kinases that have been implicated in this process. Also, within the tyrosine kinases involved in CaM phosphorylation are receptors with tyrosine kinase activity, such as the insulin receptor and the epidermal growth factor receptor, and nonreceptor tyrosine kinases, such as the Src family kinases, Janus kinase 2, and p38Syk. CaM phosphorylation brings important consequences for the physiological cell function and the cell growth as the phosphoCaM species have differential actions as compared with nonphosphorylated CaM when acting on different CaMdependent systems. 36 
Regulation of Cyclin/CDK Activity
The activity of CDKs is controlled not only by Ca 2ϩ /CaM and cyclins, but also by CDK inhibitors (CKIs). Growth promotion is associated with upregulation of cyclins and CDKs and downregulation of CKIs, and the reverse occurs during growth arrest. The p16(INK4a), p21(Cip1/Waf1), p27(Kip1), and p57(Kip2) are known inhibitors of CDK. 23, 37, 38 Studies have shown that PPAR-␣, a nuclear receptor that regulates lipid metabolism and inflammation, controls VSM cell cycle progression at the G 1 /S transition by targeting the CKI p16(INK4a). 39 Also, downregulation of p27(kip1) and p57(kip2) in response to mitogenic stimulation plays a key role in the VSM cell cycle progression. 38 Additionally, the mitogenic effect of hyperlipemic sera and oxLDL in VSMC may occur via inhibition of p21(Cip1) expression and subsequent increase in DNA synthesis and cell proliferation. 22 Furthermore, antioxidants not only downregulate cyclins D and E and CDKs 2 and 4, but also upregulate p21(Cip 1) and p27(Kip 1), leading to inhibition of CDK and arrest of cell cycle progression. 23 40 Expression of the human prodynorphin gene, which is involved in memory acquisition and pain, is regulated through its downstream regulatory element (DRE) sequence. The transcriptional repressor DRE-antagonist modulator (DREAM) specifically binds to the DRE. DREAM contains 4 Ca 2ϩ -binding domains of the EF-hand type. On stimulation by Ca 2ϩ , the ability of DREAM to bind to the DRE and its repressor function are prevented. Mutation of the EF-hands abolishes the response of DREAM to Ca 2ϩ . Also, S100B, a dimeric EF-hand Ca 2ϩ -binding protein, interacts with the cell growth suppressor p53 and controls its transcriptional activity. 41 Finally, the effect of other cations on the VSM cell cycle remains to be clarified. For instance, Mg 2ϩ is known to affect Ca 2ϩ entry into VSM and to counteract the effects of Ca 2ϩ on VSM contraction. However, studies have shown VSM cell cycle activation and growth regulation by Mg 2ϩ via ERK1/2-dependent, p38 MAP kinase-independent pathways. 42 Thus Ca 2ϩ remains to be a master regulator of VSM contraction and growth. Several studies have clarified the role of CaM as a major Ca 2ϩ sensor that regulates the activity of VSM channels, pumps, and contractile proteins. New careful studies are now beginning to shed light on the intricate interaction between Ca 2ϩ , CaM, and cyclins in the regulation of VSM growth and proliferation.
